Keith Katkin Insider Trading $SNDX Syndax Pharmaceuticals Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith Katkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith Katkin. Keith Katkin is Sr. V.P. of Sales & Marketing in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Carbylan Therapeutics, Inc. ($CBYL) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in Novus Therapeutics, Inc. ($NVUS) and PEO;CEO-Urovant Sciences,Inc. in Urovant Sciences Ltd. ($UROV) and PEO;CEO/Urovant Sciences, Inc. in Urovant Sciences Ltd. ($UROV).
Keith Katkin in Syndax Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin:
Holdings: 16,000 shares
Current Value: $139,040
Latest Transaction: Feb 05 2021
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Keith Katkin in Syndax Pharmaceuticals Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVNR, ELDN, KALV, RIGL, SNDX, UROV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Katkin Keith | Grant | A | 0.00 | 16,000 | 0 | 16,000 | 0 to 16 K | |
| Feb 14 2020 | SNDX | Syndax Pharmaceuti ... | Katkin Keith | Option Exercise | A | 9.47 | 24,000 | 227,280 | 24,000 | ||
| Jun 12 2019 | SNDX | Syndax Pharmaceuti ... | Katkin Keith | Option Exercise | A | 7.88 | 24,000 | 189,120 | 24,000 | ||
| May 25 2018 | SNDX | Syndax Pharmaceuti ... | Katkin Keith | Option Exercise | A | 8.93 | 14,000 | 125,020 | 14,000 | ||
| Feb 12 2018 | SNDX | Syndax Pharmaceuti ... | Katkin Keith | Option Exercise | A | 9.63 | 10,000 | 96,300 | 10,000 | ||
| May 19 2017 | SNDX | Syndax Pharmaceuti ... | Katkin Keith | Option Exercise | A | 13.58 | 10,000 | 135,800 | 10,000 | ||
| Mar 31 2017 | SNDX | Syndax Pharmaceuti ... | Katkin Keith | Option Exercise | A | 13.78 | 25,000 | 344,500 | 25,000 |
Page: 1